The FDA has approved GSK’s MenABCWY vaccine—the first pentavalent conjugate capable of protecting against five key meningococcal serogroups—marking …
The FDA has approved GSK’s MenABCWY vaccine—the first pentavalent conjugate capable of protecting against five key meningococcal serogroups—marking …
Parliament clears significant updates to the UK’s Clinical Trials Regulations—streamlining informed consent and laying the groundwork for improved …
The TROPION-Breast01 phase III study shows that while the ADC datopotamab deruxtecan (Dato-DXd) improves progression-free survival, it does …
With increasing geopolitical disruptions and shifting trial strategies, India emerges as an attractive destination for early-stage clinical trials, …
Grace Therapeutics reports that its Phase III STRIVE-ON trial showed GTx-104 significantly reduces clinically significant hypotension and improves …
Acadia Pharmaceuticals advances its serotonin 5-HT₂A inverse agonist, remlifanserin (ACP-204), into the final phases of clinical testing as …
A pioneering personalized cancer vaccine, designed using tumor-specific neoantigens, has achieved remission in all nine advanced kidney cancer …
Nerandomilast (BI 1015550), an oral PDE4B inhibitor, demonstrated a statistically significant improvement in lung function over 52 weeks …
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) modernizes its clinical trial framework with major updates to …
New clinical-stage anti-obesity therapies began breaking ground—designed not just to shed pounds, but to retain muscle, offering a …
